We present a relatively uncommon case of renovascular hypertension in a 61-year-old male with a history of unsatisfactory blood pressure level for 4 months and being diagnosed as intractable hypertension. Selective renal angiography by brachial artery was performed and the result revealed a normal renal artery on the left and two renal arteries supplying the right kidney, in which upper right renal artery (accessory artery) was associated with 85% stenosis. Percutaneous transluminal renal angioplasty (PTRA) was successfully performed with the stent of Promus Element 4.0*16 mm being implanted in the target artery after predilatation.
OBJECTIVES Furin protease enzyme is a protein transformation inside the cell. Metabolc syndrome (Mets) is a complex disease influenced by multiple genetic and environmental factors. The Uygur ethnic group is characterized by a relatively high prevalence of Mets. Previous research indicates that the FURIN gene may play a pivotal role in the renin-angiotensin system, maintaining the sodium electrolyte balance and glucose metabolism, lipid metabolism. Because these systems influence Arteriosclerosis, we considered FURIN as a candidate gene for Arteriosclerosis.The purpose of this study was to systematically investigate the association between genetic variations in the FURIN gene and Mets in a Xinjiang Uygur population.
METHODS To investigate the relationship between Furin gene polymorphism and metabolc syndrome in Xinjiang Uygur population. Methods: according to different Waist circumference, body mass index, blood glucose level, blood pressure, blood lipids levels,1134 individual in xinjiang hetian area were divided into 2 groups that is 707 patients with MetS and 474 non-MetS subjects. selecting representative variant in application of TaqMan-PCR in a large population of genotype identification and case-control study. Based on HapMap and NCBI databases we selected the polymorphism rs2071410 SNP (htSNP) sufficiently covering the genetic variation of the whole gene. We therefore examined the association between rs2071410 Furin and in the Xinjiang Uygur population in two independent study populations; The genotype and allele frequencies and relative clinic data were compared among groups.
RESULTS
The rs2071410 variant was associated with MetS in Uygur subjects (P¼0.010). Logistic regression analysis indicated that TT genotype of rs2071410 variation is a risk factor for MetS (OR¼1.471, P¼0.013). Further analysis found that the level The blood pressure, blood sugar, LDL related to homozygote TT were higher than CC and CT, that is to say the role of homozygote TT was Increase the risk of MetS CONCLUSIONS Our study suggested that the rs2071410 polymorphism of Furin gene is associated with Mets in ethnic Uygur population from Xinjiang, China.
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Morning Blood Pressure Surge is Associated with Cystatin C in Essential Hypertensive Patients Dengfeng Gao, Huijuan Kou, Rui Ma Second affiliated hospital of Xi'an Jiaotong University OBJECTIVES Morning blood pressure surge (MBPS), defined as a morning SBP increase from sleep SBP, is considered to be an independent risk factor for cardiovascular diseases. Whether MBPS was associated with cystatin C, a marker of early renal injury has not been previously studied.
METHODS
We included 673 hypertensive patients who had ambulatory blood pressure monitoring at our hospital from 2013 to 2014. Mean age was 59.4 þ/-12.1 years. 69% were receiving antihypertensive drug treatment. Kidney function was evaluated by measuring serum cystatin C. Glomerular filtration rate (GFR) was estimated using the abbreviated Modification of Diet in Renal Disease equations. The ambulatory BP was measured non-invasively for 24h by the Spacelab devices programmed to measure BP every 20 min during daytime and every 30 min during nighttime.
RESULTS
The highest quartile of cystatin C distribution showed an older age and worse parameters of renal function (cystatin C, serum creatinine and eGFR) than the other groups. No differences for gender or diabetes were found. MBPS was higher in the fourth quartile compared to the fist one (P <0.01). The relationship between cystatin C, as well as eGFR, with MBPS was statistically significant as renal function comes down (r¼0.34 and r¼0.41, all P <0.001). Multivariate regression analysis, MBPS was independently associated with age (P ¼0.01), dipping status (P <0.001) and cystatin (P <0.001).
CONCLUSIONS MBPS was independently associated with serum cystatin C level in essential hypertensive patients.
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The impact of different periods of dynamic pulse pressure index on the target organ damage in hypertensive patients Xudong Wang, Yanchun Ding Department of Cardiology V, the Second Affiliated Hospital of Dalian Medical University OBJECTIVES To explore the impact of different periods the dynamic pulse pressure index (PPI) on hypertensive target organ damage (TOD).
METHODS 553 hypertensive patients were enrolled. 24-hour, day and night PPI were calculated based on 24-hour ambulatory blood pressure measurement results. Each period of PPI were divided into PPI<0.4 group and PPI!0.4 group. All patients were examined by echocardiography, incidence of the TOD of heart, brain, carotid, renal and retinal in hypertensive patients in 24-hour, daytime and nighttime PPI!0.4 group were higher than that of the PPI<0.4 group (P<0.05). 4. Correlation analysis shows that the evidences of heart, brain, carotid, renal and retinal damage are positively correlated with 24-hour, day and night PPI. 5. Stepwise regression analysis shows that in hypertensive patients increasing daytime PPI is independent risk factor for left ventricular hypertrophy; nighttime PPI increasing is an independent risk factor for increasing of IMT and CysC. CONCLUSIONS 1. PPI has gender difference. Female is predominant in PPI!0.4 group. 2. The 24-hour, daytime and nighttime PPI of hypertensive patients with TOD are significantly higher than those without TOD. 3.The incidence of different hypertensive TOD in 24-hour, daytime and nighttime PPI!0.4 group is higher than that in PPI<0.4 group. 4. There are different effects of different periods PPI on hypertensive TOD, while increasing daytime PPI is an independent risk factor for left ventricular hypertrophy and increasing nighttime PPI is an independent risk factor for IMT thickening and kidney damage. OBJECTIVES To evaluate the expressions of soluble vascular endothelial growth factor receptor 2 (sVEGFR2) and visfatin in plasma of hypertensive and hypertensive diabetic patients. And to explore the correlation between sVEGFR2 and visfatin in the whole study population.
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METHODS
In this cross-sectional study, eighty-eight cases were enrolled, which were divided into hypertensive group (n¼31), hypertensive diabetic group (n¼31) and control group (n¼26). Blood pressure was obtained from each participant with mercury sphygmomanometer. The expressions of sVEGFR2 and visfatin were measured by ELISA. Serum lipid profile, glucose and glycosylated hemoglobin A1C (GHbA1c) levels were detected.
RESULTS
The levels of total cholesterol (TC) and body mass index (BMI) were significantly higher in the hypertensive group than those in control group (P<0.05). The levels of TC, triglyceride (TG), low density lipoprotein cholesterol (LDL-C), BMI, waist circumference were significantly higher in the hypertensive diabetic group than those in control group (P<0.05). The mean plasma level of sVEGFR2 in both hypertensive diabetic group and hypertensive group was significantly decreased compared to that in the normal group (P<0.05). While the mean plasma level of sVEGFR2 in hypertensive diabetic group were significantly decreased compared to the hypertensive group (P<0.05). And the mean plasma level of visfatin in both hypertensive diabetic group and only hypertensive group was significantly increased compared to that in the normal group (P<0.05), and more increased in hypertensive diabetic patients. (P<0.05). Moreover, there was a significantly negative correlation between sVEGFR2 and visfatin in the whole study population (r¼ -0.497, P<0.01).
CONCLUSIONS Soluble VEGFR2 expression is decreased in both hypertensive and hypertensive diabetic patients, and more decreased in hypertensive diabetic patients. This study indicates that decreased sVEGFR2 level may be associated with to the increase of visfatin.
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The prevalence and risk factors of postprandial hypotension in patients with coronary heart disease Yanan Zhang, Tianlei Chen, Wei Cui Department of Cardiology, Second Hospital of Hebei Medical University OBJECTIVES The main feature of postprandial hypotension(PPH) is the blood pressure being lower compared with that before a meal, and it may lead to syncope, fall, dizziness, nausea, visual disturbance, cardiovascular events, brain stroke and even death when it has a sharply fall. This study focuses on patients with coronary heart disease to explore the prevalence of PPH among patients with coronary heart disease and relevant risk factors.
METHODS Choose 289 patients with coronary heart disease, age range: 24-90, average age: 62.00AE12.22 years old. All patients are divided into different groups on the basis of age and different groups by basic systolic blood pressure level. The blood pressure of patients need to be measured before breakfast, lunch and dinner as well as 30, 60, 90 and 120min after meals.
RESULTS
The systolic blood pressure of a total of 50 cases of 289 patients drops !20mmHg, and the prevalence of PPH is 17.30%. There are 28 males (9.69%) and 22 females (7.61%) and the prevalence difference of PPH has no statistical significance (P>0.05). The difference of PPH among patients with diabetes, cerebrovascular disease, hypertension, hyperlipemia has no statistical significance (P>0.05). Among patients with taking medications which affect the blood pressure the prevalence is 15.57%; and the patients without taking medications which affect the blood pressure have PPH along with incidence is 1.73%; the difference of PPH has statistical significance (P<0.05). The prevalence of PPH for different age groups has no statistical significance (P>0.05). The prevalence of PPH of breakfast, lunch and dinner is 8.10%, 5.19% and 9.00%, the prevalence of different mealtime has no statistical significance (P>0.05). Taking medications which affect the blood pressure and basic blood pressure level are risk factors for PPH and corresponding OR is 4.05(95%CI 1.52-10.79) and 1.84 (95%CI 1.37-2.49). But in the hospital, there is no statistical difference in the adverse cardiovascular events between the patients with PPH and other patients.
CONCLUSIONS The prevalence of PPH for patients with coronary heart disease is 17.30%. There is no oblivious relevance between PPH and gender, age, body position during meal and whether patients have high blood pressure, hyperlipidemia, diabetes and cerebral vascular disease. Taking medications which affect the blood pressure and basic blood pressure level are risk factors for PPH.
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Renal sympathetic denervation for refractory hypertension after renal artery stent placement OBJECTIVES Since renal sympathetic denervation (RDN) has been recently shown to be an attractive new method in treating the patient with resistant hypertension, we decided to proceed with RDN after discussion with the patient.
METHODS
The dosage of Iohexol contrast was 75 ml. The duration of procedure was 55 minutes. The number of ablation point was 6 on both sides. The left renal artery underwent ablation using routine method.The duration of procedure was 55 minutes. The number of ablation point was 6 on both sides. The left renal artery underwent ablation using routine method.
RESULTS
In this case report, we have successfully treated a patient with resistant hypertension, who underwent renal artery stent implantation.
CONCLUSIONS This is in accordance with previous reports that RDN is well tolerated and a safe procedure. To best of our knowledge, there are very few studies that RDN procedure was conducted in patient who underwent renal artery stent implantation. Out finding suggest that continued research into the RDN for the treatment of resistant hypertension in selected patients is of interest. METHODS 142Chinese hypertensives were enrolled in this study. Hypertensive patients were divided into 3 groups: Irbesartan treated (150 mg/day, n¼42), diltiazem treated (90 mg/day, n¼50), and combined therapy ( Irbesartan 150 mg/dayþ diltiazem 90 mg/day, n¼50). 26 normotensives without cardiovascular risks served as control group. Flow-mediated dilatation (FMD) induced by reactive hyperemia was used to determine endothelium-dependent dilatation (EDD) and nitroglycerin-mediated dilatation (NMD) induced by nitroglycerin was used to determine endothelium-independent dilatation (EID) respectively in brachial arteries using high-resolution vascular ultrasound. Left ventricular mass index (LVMI) was evaluated by echocardiography, Blood pressure (BP) and fibrinogen (Fg) was monitored at baseline and after treatment. All subjects were followed up for 1 year.
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RESULTS BP, LVMI, Fg were higher and FMD and NMD were lower in hypertensive patients than those in normotensive controls at baseline. After 1-year treatment, there was a significant increase of FMD in combined therapy group compared with irbesartan treated group and diltiazem treated group [(8.31AE3 .09)% vs (10.68AE3.51)%, P<0.05], after stratification of age, while there was no significant difference in NMD after therapy among three groups (P>0.05). FMD decreased obviously with the increase of age, which turned out to be not so obviously after irbesartan combined with diltiazem treatment compared with normotensive controls. In addition, Fg decreased significantly after treatment in combined therapy group [(3.57AE0.78 CONCLUSIONS Irbesartan combined with diltiazem therapy could improve the endothelium dependent vasodilatation in essential hypertensives significantly, regardless of age, further reduced LVMI and Fg more obviously compared with monotherapy. Therefore, irbesartan combined with diltiazem might be more beneficial for reducing the cardiovascular complications in hypertensives and presented superior cardiovascular protection than monotherapy.
